Clinical trial

REal-life ON PARKinson's - ITaly (REONPARK-IT)

NCT07403799

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2025-07-08

PhaseN/A

Study timeline

Study start (actual)2025-07-08Date precision: day

Registry last updated2026-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Opicapone 50 mgDRUG · verified · RxNorm: opicapone 50 MG

Sponsors & collaborators

Bial - Portela C S.A.lead sponsor

Mapped research locations

RomaItaly4 MilanItaly2 GenovaItaly1 PaviaItaly1 PisaItaly1 BresciaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07403799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.